Forte BiosciencesFBRX
13F holders, Q3 2024 (September 30)24holders
$5.59avg. 13F price*
At the end of Q3 2024, 24 institutions reported holding Forte Biosciences Inc. (FBRX) in their 13F filings. The largest holders were Tybourne Capital Management (hk) Ltd. ($810K), BVF Inc. ($668K) and Perceptive Advisors LLC ($535K).
- Company
- Forte Biosciences Inc.
- CUSIP
- 34962G208
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $51 |
| Exits | 0 | $0 |
Ownership 24 holders
| Tybourne Capital Management (hk) Ltd. | 0.23% | No change | 144,981 | $810K |
| BVF Inc. | 0.02% | No change | 119,282 | $668K |
| Perceptive Advisors LLC | 0.01% | Reduce -26.7% | 95,742 | $535K |
| Fred Alger Management, LLC | 0.00% | Add +12.4% | 82,698 | $462K |
| Cable Car Capital, LP | 0.51% | No change | 81,279 | $454K |
| Farallon Capital Management, L.L.C. | 0.00% | No change | 72,413 | $406K |
| BML Capital Management, LLC | 0.23% | No change | 70,468 | $394K |
| Vanguard Group Inc. | 0.00% | Reduce -0.8% | 26,394 | $148K |
| Geode Capital Management, LLC | 0.00% | Add +3.0% | 14,270 | $80K |
| Susquehanna International Group, LLP | 0.00% | Add +853.3% | 13,096 | $73K |
| BlackRock, Inc. | 0.00% | — | 6,803 | $38K |
| ADAR1 Capital Management, LLC | 0.01% | Reduce -5.8% | 6,000 | $34K |
| UBS Group AG | 0.00% | Add +65.2% | 1,606 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +27.6% | 806 | $5K |
| Group One Trading LLC | 0.00% | Reduce -0.3% | 559 | $3K |
| Morgan Stanley | 0.00% | Reduce -0.8% | 151 | $844 |
| Bank of America Corp. | 0.00% | Add +117.0% | 23 | $129 |
| Osaic Holdings, Inc. | 0.00% | Reduce -53.7% | 20 | $112 |
| Russell Investments Group, Ltd. | 0.00% | Reduce -0.7% | 18 | $100 |
| BNP Paribas Financial Markets | 0.00% | New | 8 | $45 |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0.00% | Reduce -9.3% | 7 | $32 |
| JPMorgan Chase & Co. | 0.00% | Add +341.2% | 3 | $17 |
| REAP Financial Group, LLC | 0.00% | Reduce -22.7% | 3 | $17 |
| Barclays PLC | 0.00% | New | 1 | $6 |
"% of holder's portfolio" is FBRX's weight in each manager's 13F, not the share of Forte Biosciences Inc. the manager owns.